A research team led by Professor Seokho Kang of Urology (Professor Seokho Kang, Professor Shim Ji-sung, Professor Roh Tae-il, ...

Photocure ASA ( (PHCUF) ) has shared an announcement. Photocure ASA reported record revenues for its Hexvix®/Cysview® products in the second quarter of 2025, driven by strong performance in the U.S.

Key Takeaways Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 ...

A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high ...

OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...

A cystoscopy, also known as a bladder scope, is a medical test used to check for diseases of the bladder and urethra. Learn more about the purpose and risks of this procedure.

Do you have bladder cancer? No matter what symptoms you have, only your doctor can tell you for sure. WebMD describes the tests he’ll use to let you know for sure.

Bladder cancer is diagnosed by cystoscopy, a procedure in which the urologist passes a lighted telescope through the urethra into the bladder and looks directly at the inside lining of these ...

Blue Light Cystoscopy (BLC) uses an FDA-approved imaging agent—not a dye—that makes cancer cells glow bright pink under blue light. The BLC procedure uses both white and blue lights to help ...

About Bladder Cancer Bladder cancer ranks as the seventh most common cancer worldwide with 1 720 000 prevalent cases (5-year prevalence rate) 1a, 573 000 new cases and more than 200 000 deaths ...